Related Experiment Video
Updated: May 9, 2026

Analyzing Protein Dynamics Using Hydrogen Exchange Mass Spectrometry
Published on: November 29, 2013
Analysis of conformational determinants underlying HSP90-kinase interaction
Rama Krishna Kancha1, Natalie Bartosch, Justus Duyster
1Department Medicine I, University Medical Center Freiburg, Freiburg, Germany.
Abstract:
The role of HSP90 in stabilization of oncogenic tyrosine kinases made it an attractive therapeutic target for treating cancer but the molecular basis underlying the interaction between the HSP90 chaperone and client kinases is not elucidated yet. Using kinase inhibitors we show that the inactive conformation of ERBB2 does not interact with HSP90 chaperone and is thus not amenable to degradation upon HSP90 inhibitor treatment, while active ERBB2 kinase conformation promotes interaction with the HSP90 machinery and thus is degraded upon HSP90 inhibitor treatment. Interestingly, the kinase-chaperone interaction is disrupted in case of BCR-ABL and FLT3-ITD when bound to inhibitors irrespective of whether they block the kinase in an active or inactive conformation and thus our results indicate that the stability of the active kinase conformation varies between different kinases.
Insights
Heat shock protein 90 (HSP90) stabilizes oncogenic kinases. Active ERBB2 interacts with HSP90 for degradation, while inactive ERBB2 does not. Kinase inhibitor binding affects HSP90 interactions differently across various kinases.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Heat shock protein 90 (HSP90) is crucial for stabilizing oncogenic tyrosine kinases, making it a promising cancer therapeutic target.
- The precise molecular mechanisms governing the interaction between HSP90 and its client kinases remain incompletely understood.
Purpose of the Study:
- To investigate the relationship between kinase conformation and HSP90 interaction.
- To determine how kinase inhibitors affect the HSP90 chaperone-client kinase complex.
- To elucidate the differential stability of active kinase conformations.
Main Methods:
- Utilized various kinase inhibitors to probe interactions.
- Analyzed the binding of ERBB2 to HSP90 in different conformational states.
- Examined HSP90 interactions with BCR-ABL and FLT3-ITD in the presence of inhibitors.
Main Results:
- Inactive ERBB2 does not interact with HSP90 and is resistant to HSP90 inhibitor-induced degradation.
- Active ERBB2 readily interacts with HSP90 and undergoes degradation upon HSP90 inhibition.
- HSP90-kinase interactions are disrupted by inhibitors for BCR-ABL and FLT3-ITD, regardless of the inhibited conformation.
- The stability of the active kinase conformation varies significantly among different kinases.
Conclusions:
- Kinase conformation dictates HSP90 interaction and subsequent degradation.
- HSP90 inhibitor efficacy is dependent on both kinase conformation and specific kinase identity.
- Understanding these interactions is key to developing more effective targeted cancer therapies.
More Related Videos
Related Concept Videos
Molecular Chaperones and Protein Folding
The...
Protein Folding
Conserved Binding Sites
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally analyses the...
Protein Complex Assembly
Many viruses self-assemble into a fully functional unit using the infected host cell to...
Protein-protein Interfaces

